IP Library Patent Application 10590986
Patent Application
App. No. 10/590,986

D-ribose for improving depression-like symptoms

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/590,986
Abstract

An agent for improving depression-like symptoms comprising D-ribose, which may improve an alleviate various symptoms such as hypobulia, general fatigue, sluggishness, enervation, deterioration in concentration, memory impairment, abnormal sensation/obtundation such as impaired sight, decline in thinking power, indefinite complaint, drop in operation efficiency, or feeling of malaise, etc.

Claims (13)

1 . A method for improving depression-like symptoms, which comprises:

administering to a patient in need thereof an effective amount of D-ribose.

2 . The method for improving depression-like symptoms according to claim 1 , wherein the depression-like symptoms are hypobulia, general fatigue, sluggishness, enervation, deterioration in concentration, memory impairment, abnormal sensation/obtundation such as impaired sight, decline in thinking power, indefinite complaint, drop in operation efficiency, or feeling of malaise.

3 . The method for improving depression-like symptoms according to claim 1 or 2 , wherein the depression-like symptoms are depression-like symptoms accompanied by mental overstrain or mental disorder.

4 . The method for improving depression-like symptoms according to claim 1 or 2 , which comprises administering D-ribose in an amount of 10 mg to 100 g per day for an adult.

5 . The method for improving depression-like symptoms according to claim 1 or 2 , which further comprises administering at least one of a magnesium salt, an amino acid and carnitine.

6 . The method for improving depression-like symptoms according to claim 1 or 2 , which further comprises administering potassium magnesium aspartate.

7 . A composition, which comprises:

D-ribose; and

at least one of a magnesium salt, an amino acid and carnitine.

8 . A food or drink for improving depression-like symptoms, which comprises D-ribose.

9 . A method for improving mental fatigue, which comprises:

administering to a subject in need thereof and effective amount of D-ribose.

Assignments (2)
CHANGE OF NAME Recorded Nov 1, 2007
From: TANABE SEIYAKU CO., LTD.
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020053/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2006
From: YAMAMURA, MICHIO; HAYASHIDA, KOUKICHI; TSUCHIDA, TOSHITO
To: TANABE SEIYAKU CO., LTD.
Reel/Frame 018254/0950 →